Clinical trialNCT06056830RecruitingPhase 3Interventional

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

SponsorClarity Pharmaceuticals LtdEnrollment383Prostate CancerProstatic Neoplasms

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Clarity Pharmaceuticals
Clarity Pharmaceuticals
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

31 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia

St. Vincent'S Sydney
Sydney, New South Wales, Australia
Recruiting
Princess Alexandra Hospital
Woolloongabba, Queensland, Australia
Recruiting
Fiona Stanley Hospital
Murdoch, Western Australia, Australia
Recruiting

Puerto Rico

Pan American Center for Oncology Trials, Llc - Ciudadela
San Juan, Puerto Rico
Ricardo F Sanchez Ortiz, MD, FACS
Recruiting

United States

University of Alabama Birmingham Hospital
Birmingham, Alabama, United States
Jonathan E McConathy, MD, PhD
Recruiting
Mayo Clinic- Phoenix
Phoenix, Arizona, United States
Recruiting
Arkansas Urology Research Center, Llc
Little Rock, Arkansas, United States
R. Jonathan Henderson, MD
Recruiting
Greater Los Angeles Va Medical Center
Los Angeles, California, United States
Recruiting
Urology Group of Southern California
Los Angeles, California, United States
John Kowalczyk
Recruiting
Uc Irvine Health
Orange, California, United States
Edward Uchio, MD, FACS, CPI
Recruiting
Stanford University Medical Center
Stanford, California, United States
Recruiting
Mayo Clinic- Jacksonville
Jacksonville, Florida, United States
Recruiting
Biogenix Molecular, Llc
Miami, Florida, United States
Serguei A Castaneda, MD
Recruiting
Northshore University Health System, Glenbrook Hospital
Glenview, Illinois, United States
Recruiting
Indiana University School of Medicine
Indianapolis, Indiana, United States
Clint D Bahler, MD
Recruiting
Wichita Urology Group
Wichita, Kansas, United States
Timothy Richardson, MD
Recruiting
Bamf Health
Grand Rapids, Michigan, United States
Harshad Kulkarni, MD
Recruiting
Corewell Health
Grand Rapids, Michigan, United States
Conrad Tobert
Recruiting
Mayo Clinic- Rochester
Rochester, Minnesota, United States
Recruiting
Xcancer Omaha Llc
Omaha, Nebraska, United States
Luke Nordquist, MD
Recruiting
Mount Sinai Doctors Urology Faculty Practice
New York, New York, United States
Ashutosh Tewari, MD
Recruiting
Duke University Medical Center
Durham, North Carolina, United States
Judd W Moul, MD, FACSTerence Z Wong, MD, PhD, FACR
Recruiting
Urologic Specialists
Tulsa, Oklahoma, United States
Recruiting
Oregon Urology
Springfield, Oregon, United States
Recruiting
Carolina Urologic Research Center
Myrtle Beach, South Carolina, United States
Neal Shore, MD
Recruiting
Urology Associates of Nashville
Nashville, Tennessee, United States
Recruiting
University of Texas Southwestern Medical Center
Dallas, Texas, United States
Recruiting
Urology Clinics of North Texas
Dallas, Texas, United States
Recruiting
the Urology Place
San Antonio, Texas, United States
Recruiting
Intermountain Health
Murray, Utah, United States
Recruiting
University of Wisconsin
Madison, Wisconsin, United States
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

64Cu-SAR-bisPSMA

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 21 Dec 2023
Primary completion: 30 Sept 2026
Completion: 30 Sept 2026
Last update posted: 14 May 2026
Registered enrollment: 383
Registry id: NCT06056830

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.